The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sarepta Therapeutics Inc

Nasdaq: SRPT
Last

(U.S.) $56.37

Today's change+0.15 +0.27%
Updated November 24 9:58 AM EST. Delayed by at least 15 minutes.
 

Sarepta Therapeutics Inc

Nasdaq: SRPT
Last

(U.S.) $56.37

Today's change+0.15 +0.27%
Updated November 24 9:58 AM EST. Delayed by at least 15 minutes.

Sarepta Therapeutics Inc up (U.S.)$0.15

Sarepta Therapeutics Inc is up today by (U.S.)$0.15 or 0.27% to (U.S.)$56.37. Over the last five days, shares have gained 0.46% and are currently 2.08% off of the 52-week high. Shares have outperformed the S&P 500 by 30.45% during the last year.

Key company metrics

  • Open(U.S.) $56.22
  • Previous close(U.S.) $56.22
  • High(U.S.) $56.58
  • Low(U.S.) $56.07
  • Bid / Ask(U.S.) $56.33 / (U.S.) $56.47
  • YTD % change+105.50%
  • Volume31,489
  • Average volume (10-day)1,873,124
  • Average volume (1-month)1,937,086
  • Average volume (3-month)2,616,116
  • 52-week range(U.S.) $26.26 to (U.S.) $57.57
  • Beta1.33
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.04
Updated November 24 9:58 AM EST. Delayed by at least 15 minutes.
S&P TSX0.18%Sector:HealthcareIndustry:Biotechnology

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue4635165
Total other revenue--------
Total revenue4635165
Gross profit4334165
Total cost of revenue3100
Total operating expense92985694
Selling / general / administrative28362623
Research & development34592971
Depreciation / amortization1------
Interest expense (income), net operating--------
Unusual expense (income)263----
Other operating expenses, total--------
Operating income-46-63-39-88
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets00125--
Other--------
Income before tax-46-6386-88
Income after tax-48-6384-88
Income tax, total202--
Net income-48-6384-88
Total adjustments to net income--------
Net income before extra. items-48-6384-88
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-48-6384-88
Inc. avail. to common incl. extra. items-48-6384-88
Diluted net income-48-6384-88
Dilution adjustment--------
Diluted weighted average shares62555655
Diluted EPS excluding extraordinary itemsvalue per share-0.78-1.151.50-1.62
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.51-1.110.05-1.62